Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Non-cash Items (2022 - 2026)

Compass Therapeutics' Non-cash Items history spans 5 years, with the latest figure at $32.5 million for Q1 2026.

  • On a quarterly basis, Non-cash Items rose 51.04% to $32.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $32.5 million, a 51.04% increase, with the full-year FY2025 number at $36.6 million, up 6223.66% from a year prior.
  • Non-cash Items hit $32.5 million in Q1 2026 for Compass Therapeutics, down from $36.6 million in the prior quarter.
  • Over the last five years, Non-cash Items for CMPX hit a ceiling of $36.6 million in Q4 2025 and a floor of $11000.0 in Q4 2023.
  • Historically, Non-cash Items has averaged $12.6 million across 5 years, with a median of $11.3 million in 2023.
  • Biggest five-year swings in Non-cash Items: tumbled 99.83% in 2023 and later surged 6223.66% in 2025.
  • Tracing CMPX's Non-cash Items over 5 years: stood at $6.3 million in 2022, then tumbled by 99.83% to $11000.0 in 2023, then soared by 5163.64% to $579000.0 in 2024, then surged by 6223.66% to $36.6 million in 2025, then decreased by 11.31% to $32.5 million in 2026.
  • Business Quant data shows Non-cash Items for CMPX at $32.5 million in Q1 2026, $36.6 million in Q4 2025, and $11.6 million in Q3 2025.